Krahasoni metodat
Shqyrtoni metodat e zgjedhura krah për krah; rreshtat që ndryshojnë janë të theksuar.
| Metoda e Variablave Instrumentalë (IV) për Inferencën Kauzale× | Analiza Kosto-Efektivitet (AKE)× | |
|---|---|---|
| Fusha | Ekonomia shëndetësore | Ekonomia shëndetësore |
| Familja | Process / pipeline | Process / pipeline |
| Viti i origjinës≠ | 1990s (modern applications) | 1984 |
| Krijuesi≠ | Angrist & Pischke (applied econometrics); rooted in econometric theory | Drummond & Stoddart (Health Economics Research Group, McMaster University) |
| Lloji | Method | Method |
| Burimi themelues≠ | Angrist, J. D., & Pischke, J. S. (2009). Mostly Harmless Econometrics: An Empiricist's Companion. Princeton: Princeton University Press. link ↗ | Gold, M. R., Siegel, J. E., Russell, L. B., & Weinstein, M. C. (Eds.). (1996). Cost-Effectiveness in Health and Medicine. New York: Oxford University Press. link ↗ |
| Emërtime të tjera≠ | IV, two-stage least squares, TSLS, causal estimation | CEA, ICER, Incremental Cost-Effectiveness Ratio |
| Të lidhura≠ | 3 | 5 |
| Përmbledhja≠ | Instrumental variables (IV) is an econometric method to estimate causal effects when treatment or exposure is not randomly assigned and confounding is severe or unmeasured. IV relies on a third variable (instrument) that influences treatment but does not directly affect the outcome, allowing researchers to isolate the causal effect from the noise of confounding. Developed extensively in econometrics (Angrist & Pischke, 1990s–2000s), IV methods are increasingly used in health economics and health services research to leverage natural experiments and policy changes. | Cost-effectiveness analysis compares the incremental cost per unit of health benefit gained by one intervention relative to a comparator (standard care or best alternative). Developed rigorously in the 1980s by Drummond, Stoddart, and colleagues, CEA is now the standard framework for technology appraisal globally. NICE, HAS, CADTH, and other health technology assessment bodies use CEA to decide which treatments warrant public funding and at what price. |
| ScholarGateSeti i të dhënave ↗ |
|
|